BlackRock’s Significant Stake in Qiagen Revealed

Qiagen ( (QGEN) ) has shared an announcement.

Qiagen N.V., a company involved in the life sciences industry, has been notified by the Netherlands Authority for the Financial Markets (AFM) about a recent transaction involving BlackRock, Inc. The notification details BlackRock’s holdings in Qiagen, including the number of shares and voting rights, indicating a significant capital interest and voting rights percentage. This disclosure highlights BlackRock’s substantial influence within Qiagen, potentially impacting the company’s governance and strategic decisions.

The most recent analyst rating on (QGEN) stock is a Hold with a $42.50 price target. To see the full list of analyst forecasts on Qiagen stock, see the QGEN Stock Forecast page.

More about Qiagen

Average Trading Volume: 1,424,740

Technical Sentiment Signal: Strong Buy

Current Market Cap: $10.28B

For an in-depth examination of QGEN stock, go to TipRanks’ Overview page.